Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
5
×
president trump
5
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
5
×
wisconsin blog main
wisconsin top stories
biogen
medicare
novartis
abbvie
alexion pharmaceuticals
alzheimer's disease
amgen
bristol-myers squibb
cancer
cancer immunotherapy
clinical trials
What
bio
roundup
5
×
drug
alzheimer’s
biotech
patients
plan
prices
acquisitions
advantages
albert
annual
assessed
attention
august
bar
biggest
bourla
brings
busy
ceo
communities
companies
company
conference
crispr
days
decisions
devices
different
drugs
esmo
europe
expect
fail
fda
future
gamble
gene
germany
Language
unset
unknown
Current search:
pfizer
×
" president trump "
×
roundup
×
" texas top stories "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More